Discover Our Proprietary Technologies

MCO® Tech. is an original technology developed by the RnD Institute of Koru Pharma and represents the optimised conditions of the chemical reaction between the cross-linking agent and hyaluronic acid (HA)

ACAPLEX™ is a patented regenerative technology combining the KORU-ACA01 peptide with Bio-identical Type III Collagen to reinforce and protect the extracellular matrix. Designed for clinical applications, it delivers scientifically validated ECM regeneration, enzyme inhibition, and long-term structural stability.